Smoking Status shows no Impact on the Treatment Response with Adalimumab in Patients with Hidradenitis suppurativa - Results from the German Hidradenitis Suppurativa Registry HSBest

被引：0

作者：

Kirsten, Natalia ^{[1
]}

Ohm, Frenz ^{[1
]}

Gehrdau, Kathrin ^{[1
]}

Stephan, Brigitte ^{[2
]}

Ben-Anaya, Nesrine ^{[2
]}

Pinter, Andreas ^{[3
]}

Bechara, Falk ^{[4
]}

Presser, Dagmar ^{[5
]}

Zouboulis, Christos ^{[6
]}

Podda, Maurizio ^{[7
]}

Augustin, Matthias ^{[1
]}

机构：

[1] Inst Versorgungsforsch Dermatol & bei Pflegeberuf, Hamburg, Germany

[2] Univ Klinikum Hamburg Eppendorf, Inst Versorgungsforsch Dermatol & bei Pfelegeberu, Hamburg, Germany

[3] Univ Klinikum Frankfurt, Klin Dermatol Venerol & Allergol, Frankfurt, Germany

[4] Ruhr Univ Bochum, Klin Dermatol Venerol & Allergol, Bochum, Germany

[5] Univ Wurzburg UKW, Klin Dermatol Venerolo & Allergol, Wurzburg, Germany

[6] Med Hsch Brandenburg Theodor Fontane, Hsch klin Dermatol Venerol & Allergol, Dessau, Germany

[7] Klinikum Darmstadt, Klin Dermatol, Darmstadt, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P186

引用

页码：114 / 115

页数：2

共 50 条

[31] Prevalence of inflammatory bowel diseases in hidradenitis suppurativa/acne inversa population - results from the German Hidradenitis-Suppurativa-Registry HS-BEST
Ohm, Frenz
Augustin, Matthias
Zouboulis, Christos C.
Nikolakis, Georgios
Pinter, Andreas
Podda, Maurizio
Bechara, Falk G.
Presser, Dagmar
Djamei, Vahid
Ben-Anaya, Nesrine
Kirsten, Natalia
EXPERIMENTAL DERMATOLOGY, 2022, 31 : 41 - 42
[32] Hematologic Abnormalities in Patients With Hidradenitis Suppurativa Receiving Adalimumab
Gunter, Simon J.
Holcomb, Zachary E.
Lam, Barbara D.
Porter, Martina L.
Kimball, Alexa B.
JAMA DERMATOLOGY, 2024, 160 (06) : 678 - 681
[33] Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa
van Rappard, Dominique C.
Leenarts, Marjolein F. E.
Meijerink-van 't Oost, Leonie
Mekkes, Jan R.
JOURNAL OF DERMATOLOGICAL TREATMENT, 2012, 23 (04) : 284 - 289
[34] Quality of life in patients with hidradenitis suppurativa treated with adalimumab
Pantelidi, Kleoniki
Agiasofitou, Efthymia
Marnelakis, Ioannis
Kapsiocha, Anastasia
Liakou, Aikaterini I.
Rotsiamis, Nikolaos
Kontochristopoulos, Georgios
Rigopoulos, Dimitris
EXPERIMENTAL DERMATOLOGY, 2020, 29 : 50 - 50
[35] Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa
van Rappard, Dominique
Leenarts, Marjolein
Meijerink-van't Oost, Leonie
Mekkes, Jan
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S42 - S42
[36] Effect of adalimumab treatment on inflammatory and hematological parameters in patients with Hidradenitis suppurativa
Kaya, Kadir
Gevher, Ozlem
CUTANEOUS AND OCULAR TOXICOLOGY, 2024,
[37] A novel hidradenitis suppurativa efficacy variable, HiSCR (hidradenitis suppurativa clinical response), is responsive to change with adalimumab therapy: Results of a phase II study
Kimball, Alexandra B.
Williams, David A.
Jemec, Gregor B. E.
Gu, Yihua
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB40 - AB40
[38] Paling in the face of treatment of hidradenitis suppurativa: A case report of new onset vitiligo in a patient with hidradenitis suppurativa treated with adalimumab
Charlton, Olivia
Smith, Saxon
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB249 - AB249
[39] Deranged iron status in patients with hidradenitis suppurativa
Ponikowska, M.
Matusiak, L.
Kasztura, M.
Jankowska, E. A.
Szepietowski, J. C.
EXPERIMENTAL DERMATOLOGY, 2019, 28 : 28 - 28
[40] Adalimumab Treatment for Hidradenitis Suppurativa Associated with Crohn's Disease
Diamantova, Dominika
Lomickova, Iva
Cetkovska, Petra
ACTA DERMATOVENEROLOGICA CROATICA, 2014, 22 (04) : 291 - 293

← 1 2 3 4 5 →